1.Learning Objective 1: At the end of the presentation, attendees will be able to identify the three FDA approved non-invasive neuromodulation devices for headache
- Learning Objective 2: At the end of the presentation attendees will be able to prescribe each of the three devices for appropriate indications
- Learning Objective 3: At the end of the presentation, attendees will be acquainted with the current neuromodulation devices in development for headache
Session date:
07/25/2017 - 8:00am to 9:00am CDT
Location:
NorthShore - Evanston
Evanston, IL
60201
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Stewart J. Tepper, MD